Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the
coverage of the most important and influential journals
to meet the needs of the global scientific community.
Type II diabetes mellitus (T2DM) patients have increased risk for atherosclerotic cardiovascular disease (CVD), which is partly attributable to dyslipidemia. Although statins are the recommended therapeutic strategy, fenofibrate (FFB)-known to decrease TG levels, increase HDL-C, and shift the distribution of LDL subfractions towards larger, less atherogenic particles-has been recommended as adjuvant therapy with statins.
